,i #aafth ,,congress #ast ,session ,h4 ,r4 #bjfd ,,in ,,the ,,house ,,of ,,representatives ,april #c1 #bjai ,ms4 ,judy ,chu of ,california 7for herself and ,mr4 ,nunes7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xi of the ,social ,security ,act to require manufacturers of certain drugs1 devices1 biologicals1 and medical supplies to report on product samples provided to certain health care providers1 and for other purposes4 #a4 ,requirement for manufacturers of certain drugs1 devices1 biologicals1 and medical supplies to report on product samples provided to certain health care providers 7a7 ,in general ,section #aabh;,g7a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acbj;a-#g;h7a77 is amended by adding at the end the following new paragraph3 7#c7 ,certain product samples 7,a7 ,in general ,in addition to the requirements under paragraphs 7#a77;,a7 and 7#b71 on the #ijth day of each calendar year 7beginning with #bjbc71 any applicable manufacturer that provides a payment or other transfer of value that is a product sample described in subparagraph 7,b7 to any covered recipient 7or to an entity or individual at the request of1 or designated on behalf of1 such a covered recipient7 shall submit to the ,secretary1 in such electronic form as the ,secretary shall require1 the following information with respect to the preceding calendar year3 7i7 ,the total quantity of all such payments or other transfers of value provided to covered recipients4 7ii7 ,the total value of all such payments or other transfers of value provided to covered recipients4 7iii7 ,if applicable1 information described in clauses 7vii7 and 7viii7 of paragraph 7#a77;,a7 with respect to such a payment or other transfer of value4 7,b7 ,product sample described ,for purposes of subparagraph 7,a71 a product sample described in this subparagraph is a product sample that is not intended to be sold and is intended for patient use4 4 7b7 ,public availability of information ,section #aabh;,g7c77#a77;,c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acbj;a-#g;h7c77#a77;,c77 is amended-- 7#a7 in clause 7ii7-- 7,a7 by striking 7ii7 contains and inserting 7ii77,i7 with respect to information that is not information submitted under paragraph 7#c7 of subsection 7a71 contains2 7,b7 by striking 1 as applicable2 and inserting 1 as applicable2 and2 and 7,c7 by adding at the end the following new subclause3 7,,ii7 with respect to information submitted under paragraph 7#c7 of subsection 7a71 contains information that is presented by the name of the applicable manufacturer1 the total amount of all payments or other transfers of value described in such paragraph provided to covered recipients1 the total value of all such payments or other transfers of value provided to covered recipients1 and the name of the covered drug1 device1 biological1 or medical supply1 as applicable2 2 7#b7 in clause 7viii71 by striking 1 and at the end and inserting a semicolon2 7#c7 in clause 7ix71 by striking the period at the end and inserting 2 and2 and 7#d7 by adding at the end the following new clause3 7x7 in the case of information submitted under paragraph 7#c7 of subsection 7a71 lists such information separately from the other information submitted under subsection 7a7 and presents such information by the name of the applicable manufacturer1 the total quantity of all payments or other transfers of value described in such paragraph provided to covered recipients1 the total value of all such payments or other transfers of value provided to covered recipients1 and the name of the covered drug1 device1 biological1 or medical supply1 as applicable4 4 7c7 ,conforming amendment ,section #aabh;,g7e77#aj77;,b77ii7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acbj;a-#g;h7e77#aj77;,b77ii77 is amended by striking ,product samples and inserting ,except for purposes of paragraph 7#c7 of subsection 7a71 product samples4